Prevention of Nosocomial Pneumonia Pneumonia is a lower respiratory tract infection that is caused by fungi, viruses, bacteria, parasites, or protozoa. Pneumonia is so prevalent that it is the sixth leading cause of death in the United States. Risk factors include; old age, compromised immunity, smoking, underlying lung, cardiac, or liver disease, endotracheal intubation, immobilization, malnutrition, poverty, altered consciousness, and impaired swallowing (Huether and McCance, 2012). There are three main ways individuals can acquire pneumonia: nosocomial (hospital acquired), community acquired (the most common), and immuno-compromised pneumonia. Different microorganisms are associated with each of the different ways it can be acquired. Those infected with pneumonia through being in the hospital and or being immuno-compromised have a higher mortality rate than those individuals who acquire it in the community. Nosocomial pneumonia is the second most common hospital acquired infection (Huether and McCance, 2012). For the purpose of this paper, I will be focusing on nosocomial pneumonia, the pathology of the infection, and evidence based practices that have been proven to help reduce the risk of acquiring the disease. The two microorganisms most often associated in the infection of individuals diagnosed with nosocomial pneumonia are pseudomonas aeruginosa and staphylococcus aureus, including methicillin resistant staphylococcus aureus (MRSA). The routes that the microorganisms may take to invade the individual include aspiration of oropharyngeal secretions, inhalation of the microorganisms that have been released into the air when an infected person sneezes, coughs, or talks, or from aerosolized water from, for instance, contaminated respiratory therapy equipment (Huether and McCance, 2012). In the lower respiratory tract, the alveolar macrophage is the most important cell because they recognize pathogens through pattern-recognition receptors which then activate the innate and adaptive immune responses. The inflammatory response that NOSOCOMIAL PNEUMONIA 3
results from the introduction of these pathogens can cause damage to the bronchial mucous membranes and alveolocapillary membranes. The damage to these membranes causes the acini and terminal bronchioles to fill with infectious debris and exudate. Some of the infectious microorganisms release toxins from their cells walls that can cause further damage to the lungs as well as consolidation of the lung tissue (Huether and McCance, 2012). Accumulation of the exudates leads to dyspnea and hypoxemia. Nosocomial pneumonia is a common complication in the intensive care unit, most often in patients placed on mechanical ventilation (Huether and McCance, 2012). Ventilator associated pneumonia (VAP) has a mortality rate of 15% to 70% depending on the underlying condition of the affected individual. Soon after an endotracheal tube (ET) is placed, bacterial colonization of the oropharynx occurs with subsequent aspiration and pooling of bacteria by the ET tube cuff. Bacteria are capable of forming a biofilm on the surface of the tube that contributes to replication of the bacteria which can then make the microorganisms less vulnerable to antibiotics (Huether and McCance, 2012). There are various interventions and treatment protocols that have been shown to improve the outcomes regarding VAP prevention and the reduction in mortality rates related to VAP. Treatment protocols that have been implemented to reduce the chances of acquiring VAP include improving oral hygiene pre and post operation. According to Colaianne (2010), chlorhexidine is an antimicrobial oral rinse that has shown positive results in the prevention of VAP. Keeping the head of the patients bed elevated as well as providing continuous suctioning of subglottic secretions in the ET tube have been shown to decrease the risk of acquiring VAP. Ambulation of the patient and patient repositioning while in bed are also essential parts of the prevention of nosocomial pneumonia. Education of physicians, nurses, and NOSOCOMIAL PNEUMONIA 4
staff as well as effective team communication is an important component of lowering patients risks of infection. Lastly, incentive spirometry is part of the postoperative respiratory care protocol for most surgical patients hospitalized longer than 24 hours, according to Lamar (2012). An incentive spirometer is a medical device that is used to help keep patients lungs healthy and functioning properly post operatively. Nurses must teach their patients to use their incentive spirometer as often as possible, using it usually 10 times every 1-2 hours while they are awake. To use an incentive spirometer, the patient must first exhale, then place their lips around the mouthpiece and inhale slowly and deeply. The goal is to keep the ball piece in the center of the chamber during inhalation. In a study done in 2007 by the Institute for Healthcare Improvement, they used what they call the respiratory bundle (interventions provided above) to test for decreasing the risk of acquiring nosocomial pneumonia. According to the study in Lamar (2012), rapid response team calls for respiratory reasons decreased by 13% during the 12-month intervention period in the study of the general practice unit, while calls in the control GPU increased by 10% over the same time period. The article explains that the nursing staff found the easiest and most basic nursing interventions sometimes have the most impact on patient safety. For instance, reminding medical patients to use their incentive spirometers every 1 to 2 hours and providing them with good oral hygiene daily requires very little additional time and has shown positive results (Lamar, 2012). The protocols and prevention methods for nosocomial pneumonia are an essential part of nursing practice and patient safety. Because of its frequency and high mortality rates in hospitals and other inpatient facilities, it is important for healthcare staff to be educated and aware of how to prevent and decrease the risk for this disease. Following and keeping up with new research NOSOCOMIAL PNEUMONIA 5
and techniques associated with nosocomial pneumonia will help us keep our patients safe and lower their chances for future infection and disease.
NOSOCOMIAL PNEUMONIA 6
References Colaianne, B. (2010). Prevention of post-op pneumonia utilizing pre-operative oral care. AJIC: American Journal of Infection Control, 38(5), e32-e33. doi:10.1016/j.ajic.2010.04.040 Huether, E. Sue, & McCance, L. Kathryn. (2012). Understanding Pathophysiology. (5 th ed.). St. Louis, Missouri: Elsevier Mosby. Lamar, J. (2012). Relationship of respiratory care bundle with incentive spirometry to reduced pulmonary complications in a medical general practice unit. MEDSURG Nursing, 21(1), 33-37.